<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//TaxonX//DTD Taxonomic Treatment Publishing DTD v0 20100105//EN" "https://rcpp-ie.com/nlm/tax-treatment-NS0.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:tp="http://www.plazi.org/taxpub" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">143</journal-id>
      <journal-id journal-id-type="index">urn:lsid:arphahub.com:pub:892805cc-c5d0-571f-8841-3ba335035073</journal-id>
      <journal-title-group>
        <journal-title xml:lang="en">Review of Clinical Pharmacology and Pharmacokinetics – International Edition</journal-title>
        <abbrev-journal-title xml:lang="en">RCPP</abbrev-journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1011-6583</issn>
      <issn pub-type="epub">2945-1922</issn>
      <publisher>
        <publisher-name>PHARMAKON-Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.61873/YAOK3799</article-id>
      <article-id pub-id-type="publisher-id">34726</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Review Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Newer developments in the treatment of aesthetic lesions caused by excessive exposure of the skin to blue light</article-title>
      </title-group>
      <contrib-group content-type="authors">
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Koldiri</surname>
            <given-names>Elpida</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Kefala</surname>
            <given-names>Vasiliki K.</given-names>
          </name>
          <uri content-type="orcid">https://orcid.org/0000-0003-2222-8535</uri>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
        <contrib contrib-type="author" corresp="no">
          <name name-style="western">
            <surname>Rallis</surname>
            <given-names>Efstathios</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1">
        <label>1</label>
        <addr-line content-type="verbatim">Department of Biomedical Sciences, School of Health and Care Sciences, University of West Attica, Campus 1, Athens, Greece</addr-line>
        <institution>Department of Biomedical Sciences, School of Health and Care Sciences, University of West Attica, Campus 1</institution>
        <addr-line content-type="city">Athens</addr-line>
        <country>Greece</country>
      </aff>
      <author-notes>
        <fn fn-type="edited-by">
          <p>Academic editor: </p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2024</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>17</day>
        <month>02</month>
        <year>2024</year>
      </pub-date>
      <volume>38</volume>
      <issue>s1</issue>
      <fpage>43</fpage>
      <lpage>49</lpage>
      <uri content-type="arpha" xlink:href="http://openbiodiv.net/BA05EFE5-9B53-5988-B71F-C313DECDECA9">BA05EFE5-9B53-5988-B71F-C313DECDECA9</uri>
      <permissions>
        <copyright-statement>Elpida Koldiri, Vasiliki K. Kefala, Efstathios Rallis</copyright-statement>
        <license license-type="creative-commons-attribution" xlink:href="http://creativecommons.org/licenses/by/4.0/" xlink:type="simple">
          <license-p>This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <label>Abstract</label>
        <p>Blue light, with wavelengths from 400 nm to 500 nm, is an important part of the sun’s electromagnetic radiation spectrum, which is present in human daily life, especially in the modern era due to the increased use of electronic devices through their screens. Low-energy and low time of exposure to blue light can enhance the prevention of certain skin conditions such as psoriasis, eczema, and atopic dermatitis, while studies have demonstrated that prolonged exposure to high-energy blue light can increase the amount of skin damage. DNA, cell death, skin barrier and fibroblast damage, hyperpigmentation, and photoaging. Therefore, in the fields of aesthetics and cosmetology, it is important to study the problems caused by exposure to the blue radiation spectrum. Improved protection filters, extracts of plant products, a variety of antioxidants, and natural ingredients from plants and algae are added to cosmetic products and compose innovative formulations as part of a comprehensive photoprotection strategy. In recent decades, antiaging strategies have been developed that include minimally invasive treatments with remarkable safety and efficacy and reduced recovery time. A combined approach of these treatments can provide optimal results in repairing the skin damage caused by ultraviolet (UV) and visible radiation and, consequently, in the overall improvement of the appearance of photoaged skin.</p>
      </abstract>
    </article-meta>
  </front>
</article>
